Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Health In Tech, Inc.

NASDAQ: HIT · Finance · 11 alerts · CIK 2019505

Share price
$0.3298Close, Nov 16
Sector
Finance
Industry
Insurance Agents, Brokers & ServiceSIC 6411

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Health In Tech, Inc. filings on SEC EDGAR ↗

5:18 PM ET 10-Q
Financial Results

Health In Tech Q3 2026 Results: Net Loss of $7.07M

For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.

Key figure
Net loss $7.07M
5:10 PM ET 8-K
Investor Presentation

Health In Tech Investor Presentation

Health In Tech, Inc. has prepared a formal investor presentation deck to be used by management at upcoming conferences and meetings. The presentation highlights the company's AI-powered marketplace platform designed to help small- and medium-sized businesses access self-funded health plans. The filing includes the full slide deck as Exhibit 99.1 for investor review.

5:08 PM ET 8-K
Leadership Change

Health In Tech Leadership Change

Health In Tech, Inc. announced a leadership transition separating the roles of Executive Chairman and Chief Executive Officer. Founder Tim Johnson will serve as Executive Chairman focusing on long-term strategy and innovation, while Sanjay Shrestha has been appointed as the new CEO to lead day-to-day operations and commercial execution.

5:06 PM ET 8-K
Financial Results

Health In Tech Financial Results

Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.

Term
Q3 2026

“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”

Sanjay Shrestha, Chief Executive Officer of Health In Tech
8:09 AM ET 8-K
Shareholder Meeting

Health In Tech Shareholder Meeting

Health In Tech held its 2026 Annual Meeting of Stockholders where shareholders elected five directors and approved an amendment to increase authorized capital stock from 220 million to 720 million shares. Additionally, stockholders approved the potential issuance of Class A Common Stock under a Standby Equity Purchase Agreement and an amendment to the 2024 Equity Incentive Plan to increase authorized shares to 30.7 million.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.